Visual inspection of medications in preventing unexplained relapses.
Sattar
S Pirzada
SP
Gastfriend
David R
DR
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy; D001241:Aspirin / Q000008:administration & dosage; D001569:Benzodiazepines; D017332:Cetirizine / Q000008:administration & dosage; D002998:Clonazepam / Q000627:therapeutic use; D003863:Depression / Q000188:drug therapy; D005260:Female; D006801:Humans; D008508:Medication Errors / Q000009:adverse effects / Q000517:prevention & control*; D008875:Middle Aged; D000077152:Olanzapine; D010890:Pirenzepine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D055502:Secondary Prevention; D009626:Terminology as Topic
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D010890:Pirenzepine; D002998:Clonazepam; D000077152:Olanzapine; D001241:Aspirin; D017332:Cetirizine